Ligand validation:5WGX

MB5: (5aS,12aS,13aS)-9-chloro-12,12-dimethyl-2,3,11,12,12a,13-hexahydro-1H,5H,6H-5a,13a-(epiminomethano)indolizino[7,6-b]carbazol-14-one

MB5 is a Ligand Of Interest in 5WGX designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5WGX_MB5_A_718	96%	66%	0.057	0.966	0.72	0.58	-	-	0	0	100%	1
5WGX_MB5_A_719	18%	67%	0.156	0.744	0.72	0.54	-	-	0	0	100%	1
5WGW_MB5_A_714	79%	66%	0.088	0.934	0.73	0.57	-	1	0	0	100%	1
5WGY_MB5_A_714	65%	62%	0.12	0.922	0.85	0.61	1	1	0	0	100%	1
6PVF_MB5_A_502	40%	61%	0.162	0.873	0.78	0.7	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.